Ginkgo BioWorks
Latest round
- Series F
Last raised
- May 2020
Total raised
- $812M
Investors
- 15
About Ginkgo BioWorks
Founded in 2008 and based in Massachusetts, US, Ginkgo BioWorks, Inc. develops and engineers microorganisms for multiple industries, such as food, cosmetics, farming, and pharmaceuticals. The company was founded by Austin Che, Barry Canton, Jason Kelly, Reshma Shetty, and Tom Knight. In May 2020, Ginkgo BioWorks, Inc., a special purpose acquisition company, agreed to acquire Ginkgo BioWorks, Inc. The company operates a software platform that uses advanced robotic automation, data analytics, and genetic engineering to program and produce living cells like bacteria with industrial applications ranging from cheesemaking to medicine. Ginkgo Bioworks designs, engineers, develops, tests, and licenses microorganisms that can be used by other companies as microbial products for flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals., the company plans to become a publicly listed company. In 2021, Ginkgo expects to generate USD 150 million in revenue, which is approximately 96% growth compared to 2020.
Who invested in Ginkgo BioWorks
15 investors across 7 rounds
See all investors in Ginkgo BioWorks
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series F
May 28, 2020
Amount
$70M
Investors
Series E
Sep 9, 2019
Amount
$290M
Investors
Series D
Oct 31, 2017
Amount
$291M
Investors
Series C
May 19, 2016
Amount
$99M
Investors
Series B
Jul 8, 2015
Amount
$53M
Investors
Series A
Mar 18, 2015
Amount
$9M
Investors
Seed
Aug 20, 2014
Amount
$0.1M
Investors
Questions about Ginkgo BioWorks
Who invested in Ginkgo BioWorks?
Ginkgo BioWorks has 15 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ginkgo BioWorks raised?
Ginkgo BioWorks has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Ginkgo BioWorks last raise money?
Ginkgo BioWorks's most recent round on record is a Series F, in May 2020.
What does Ginkgo BioWorks do?
Founded in 2008 and based in Massachusetts, US, Ginkgo BioWorks, Inc.
Where is Ginkgo BioWorks headquartered?
Ginkgo BioWorks is headquartered in Boston, US.
Which VCs invest in companies like Ginkgo BioWorks?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ginkgo BioWorks's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Ginkgo BioWorks? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.